CAH Cardinal Health, Inc.

Price (delayed)

$47.68

Market cap

$13.94B

P/E Ratio

N/A

Dividend/share

$1.93

EPS

-$12.61

Enterprise value

$17.95B

Sector: Healthcare
Industry: Medical Distribution
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Highlights

The company's debt fell by 16% YoY and by 7% QoQ
Cardinal Health's net income has increased by 11% QoQ
The equity has shrunk by 72% YoY but it has increased by 49% QoQ
Cardinal Health's gross margin has decreased by 4.3% YoY

Key stats

What are the main financial stats of CAH
Market
Shares outstanding
292.44M
Market cap
$13.94B
Enterprise value
$17.95B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.78
Price to sales (P/S)
0.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.12
Earnings
Revenue
$152.92B
EBIT
-$3.54B
EBITDA
-$2.62B
Free cash flow
$1.59B
Per share
EPS
-$12.61
Free cash flow per share
$5.41
Book value per share
$6.13
Revenue per share
$521.92
TBVPS
$100.65
Balance sheet
Total assets
$40.77B
Total liabilities
$38.97B
Debt
$6.78B
Equity
$1.79B
Working capital
$2.33B
Liquidity
Debt to equity
3.79
Current ratio
1.1
Quick ratio
0.47
Net debt/EBITDA
-1.53
Margins
EBITDA margin
-1.7%
Gross margin
4.5%
Net margin
-2.4%
Operating margin
-2.7%
Efficiency
Return on assets
-9.1%
Return on equity
-302.3%
Return on invested capital
-33.2%
Return on capital employed
-20.6%
Return on sales
-2.3%
Dividend
Dividend yield
4.05%
DPS
$1.93
Payout ratio
N/A

CAH stock price

How has the Cardinal Health stock price performed over time

Financial performance

How have Cardinal Health's revenue and profit performed over time
Revenue
$152.92B
Gross profit
$6.87B
Operating income
-$4.1B
Net income
-$3.7B
Gross margin
4.5%
Net margin
-2.4%
Cardinal Health's net income has increased by 11% QoQ
The company's net margin rose by 11% QoQ
Cardinal Health's revenue has increased by 5% YoY
Cardinal Health's gross margin has decreased by 4.3% YoY

Growth

What is Cardinal Health's growth rate over time

Valuation

What is Cardinal Health stock price valuation
P/E
N/A
P/B
7.78
P/S
0.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.12
The company's EPS rose by 10% QoQ
The equity has shrunk by 72% YoY but it has increased by 49% QoQ
CAH's price to book (P/B) is 53% higher than its 5-year quarterly average of 5.1 but 38% lower than its last 4 quarters average of 12.6
The stock's P/S is 55% below its 5-year quarterly average of 0.2 and 10% below its last 4 quarters average of 0.1
Cardinal Health's revenue has increased by 5% YoY

Efficiency

How efficient is Cardinal Health business performance
CAH's return on equity has dropped by 71% since the previous quarter
The company's return on sales rose by 15% QoQ
CAH's return on invested capital is up by 12% since the previous quarter
Cardinal Health's return on assets has increased by 11% QoQ

Dividends

What is CAH's dividend history
DPS
$1.93
Dividend yield
4.05%
Payout ratio
N/A
Recent dividends

Financial health

How did Cardinal Health financials performed over time
Cardinal Health's total assets is 4.6% more than its total liabilities
CAH's total liabilities is up by 13% year-on-year but it is down by 2.4% since the previous quarter
Cardinal Health's current ratio has increased by 4.8% from the previous quarter and by 2.8% YoY
The company's debt to equity has surged by 198% YoY but it fell by 37% QoQ
The equity has shrunk by 72% YoY but it has increased by 49% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.